Ruoyi Ishikawa

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Ruoyi Ishikawa is an author at Hiroshima University specializing in myasthenia gravis pharmacotherapy, speech-language pathology, and myasthenia gravis.

ORCID

Publications per year

2020–2023

Publications

Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis

Takamichi Sugimoto, Kazuhide Ochi, Ruoyi Ishikawa et al. · Journal of the Neurological Sciences · 2020 · 24 citations

Medicine, Internal Medicine, Pharmacotherapy +6

Antibody-recognizing residues 188-211 of TMEM106B exhibit immunohistochemical reactivity with the TMEM106B C-terminal fragment

Ruoyi Ishikawa, Yu Yamazaki, Masahiro Nakamori et al. · Frontiers in Neuroscience · 2023 · 20 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Swallowing sound evaluation using an electronic stethoscope and artificial intelligence analysis for patients with amyotrophic lateral sclerosis

Masahiro Nakamori, Ruoyi Ishikawa, Tomoaki Watanabe et al. · Frontiers in Neurology · 2023 · 14 citations · Full text

Health Professions, Neurology, Speech-language Pathology +17

1–3 of 3